Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Acad Radiol. 2009 Sep 30;17(1):7–17. doi: 10.1016/j.acra.2009.07.027

Figure 5.

Figure 5

Ex vivo coronal images of representative examples from the U251-GFP tumor-bearing group are shown. Two example mice from the U251-GFP cetuximab treated group are shown in (A) and (B). Two example mice from the U251-GFP untreated group are shown in (C) and (D). EGF-IRDye fluorescence (row 1) was compared with GFP fluorescence (row 2) and H&E images (row 3) and demonstrated decreased fluorescence in the treated group as compared to the untreated group. Representative examples of in vivo MRI images showed that the U251-GFP tumors were difficult to detect using T1 TSE CE MRI (row 4) or T2 FLAIR MRI (row 5).